HIGHLIGHTS
- who: Early Aspirin Discontinuation Following and colleagues from the Sorbonne University, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière have published the article: Clinical Medicine, in the Journal: (JOURNAL)
- what: This systematic review and meta-analysis aims to evaluate the safety and efficacy of early aspirin discontinuation with P2Y12 inhibitors single antiplatelet therapy continuation, as compared with a strategy of sustained DAPT following an ACS or PCI, in patients with or without concomitant OAC treatment. The authors report a significant interaction between background OAC and the risk of MI associated with early . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.